iCAD to Present at the JMP Securities Life Sciences Conference on June 15-16, 2022
06 juin 2022 08h08 HE
|
iCAD, Inc.
NASHUA, N.H., June 06, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Company...
iCAD Announces CFO Transition
25 mai 2022 08h01 HE
|
iCAD, Inc.
NASHUA, N.H., May 25, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Board of...
New Real-World Evidence Shows ProFound AI Improves Cancer Detection and Accuracy with Digital Breast Tomosynthesis, or 3D Mammography
18 mai 2022 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., May 18, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that new...
New Research Finds iCAD's ProFound AI Risk for Digital Breast Tomosynthesis is 2.4x More Accurate than Traditional Lifetime Risk Models
16 mai 2022 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., May 16, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that...
iCAD Reports Financial Results for First Quarter Ended March 31, 2022
11 mai 2022 16h07 HE
|
iCAD, Inc.
NASHUA, N.H., May 11, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today reported its financial...
iCAD’s “ProFound Insights, ProFound Impact” Webinar Series to Feature Clinical and IT Experts from Wake Radiology
28 avr. 2022 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., April 28, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that the...
iCAD to Report First Quarter 2022 Financial Results on Wednesday, May 11
27 avr. 2022 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., April 27, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...
iCAD Announces Significant Commercial Momentum for ProFound AI Among Customers Equipped with the Leading Provider of 3D Mammography Systems
26 avr. 2022 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., April 26, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, announced significant...
iCAD Announces Estimated Q1 Revenue and Upcoming Board and CFO Transitions
21 avr. 2022 08h00 HE
|
iCAD, Inc.
Company expects preliminary estimated revenue to be $7.5 million Timothy Norris Irish appointed Chairman of the Board of Directors, successor CFO search underway NASHUA, N.H., April 21, 2022 ...
iCAD Launches ProFound Insights, ProFound Impact Webinar Series on April 27
19 avr. 2022 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., April 19, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...